Israel - engelska - Ministry of Health

gilead sciences israel ltd - sofosbuvir; velpatasvir - film coated tablets - velpatasvir 100 mg; sofosbuvir 400 mg - sofosbuvir - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.

Israel - engelska - Ministry of Health

gilead sciences israel ltd - sofosbuvir; velpatasvir - film coated tablets - velpatasvir 100 mg; sofosbuvir 400 mg - sofosbuvir - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.

Israel - engelska - Ministry of Health

gilead sciences israel ltd - emtricitabine; tenofovir alafenamide fumarate - film coated tablets - tenofovir alafenamide fumarate 10 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv 1).

Israel - engelska - Ministry of Health

gilead sciences israel ltd - emtricitabine; tenofovir alafenamide fumarate - film coated tablets - tenofovir alafenamide fumarate 25 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv 1).

Israel - engelska - Ministry of Health

gilead sciences israel ltd - ledipasvir; sofosbuvir - film coated tablets - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adults.

Israel - engelska - Ministry of Health

gilead sciences israel ltd - ledipasvir; sofosbuvir - film coated tablets - ledipasvir 90 mg; sofosbuvir 400 mg - sofosbuvir and ledipasvir - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adults.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - tenofovir disoproxil fumarate 300mg (as 245mg of tenofovir disoproxil);  ;  ;   - film coated tablet - 300 mg - active: tenofovir disoproxil fumarate 300mg (as 245mg of tenofovir disoproxil)       excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry blue y-30-10671-a pregelatinised maize starch - viread, in combination with other antiretroviral agents is indicated for the treatment of hiv-infected adults and paediatric patients 12 years of age and older.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - amphotericin b -

Europeiska unionen - engelska - EMA (European Medicines Agency)

gilead sciences international limited - cidofovir - cytomegalovirus retinitis - antivirals for systemic use - vistide is indicated for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome (aids) and without renal dysfunction. vistide should be used only when other agents are considered unsuitable.,

Australien - engelska - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - velpatasvir, quantity: 100 mg; sofosbuvir, quantity: 400 mg - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; copovidone; silicified microcrystalline cellulose; titanium dioxide; purified talc; iron oxide red; macrogol 4000; polyvinyl alcohol - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection (genotype 1, 2, 3, 4, 5 or 6) in adults and paediatric patients 12 years of age and older and weighing 30 kg or more.,(see 4.2 dose and method of administration section for the recommended regimens for different patient subgroups).